|
|
Blood, 15 April 2006, Vol. 107, No. 8, pp. 3034-3044.
Prepublished online as a Blood First Edition Paper on January 5, 2006; DOI 10.1182/blood-2005-09-3679.
Previous Article | Next Article 
Submitted September 15, 2005
Accepted December 5, 2005
Infection-associated lymphomas derived from marginal-zone B-cells: a model of antigen-driven lymphoproliferations
Felipe Suarez, Olivier Lortholary, Olivier Hermine, and Marc Lecuit*
Department of Hematology, Necker-Enfants Malades Hospital, Paris, France
Department of Infectious Diseases, Necker-Enfants Malades Hospital, Paris, France; Molecular Mycology Unit, CNRS FRE 2849, Institut Pasteur, Paris, France
Department of Hematology, Necker-Enfants Malades Hospital, Paris, France; CNRS UMR 8603, IFR94, Rene Descartes-Paris 5 University, Paris, France
Department of Infectious Diseases, Necker-Enfants Malades Hospital, Paris, France; Bacteria-Cell Interactions Unit, INSERM U604, Institut Pasteur, Paris, France
* Corresponding author; email: mlecuit{at}pasteur.fr.
Non-Hodgkin lymphomas develop from nodal and extranodal lymphoid tissues. A distinct subset of extranodal lymphomas arising from B-cells of the marginal zone (MZ) of mucosa-associated lymphoid tissue (MALT) or spleen has been individualized. Growing evidence indicates that MZ lymphomas are associated with chronic antigenic stimulation by microbial pathogens and/or autoantigens. Molecular investigations have allowed the lengthening of the list of microbial species associated with MZ lymphoproliferations, which now comprises at least five distinct members: H. pylori, C. jejuni, B. burgdorferi, C. psittaci, and HCV. A pathophysiological scenario involving chronic and sustained stimulation of the immune system leading to lymphoid transformation has emerged. It defines a distinct category of infection-associated lymphoid malignancies, in which the infectious agent does not directly infect nor transform lymphoid cells, as do the lymphotropic oncogenic viruses EBV, HHV8 and HTLV1, but rather indirectly increases the probability of lymphoid transformation by chronically stimulating the immune system to maintain a protracted proliferative state.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Borie, M. Wislez, G. Thabut, M. Antoine, A. Rabbat, L-J. Couderc, I. Monnet, H. Nunes, F-X. Blanc, H. Mal, et al.
Clinical characteristics and prognostic factors of pulmonary MALT lymphoma
Eur. Respir. J.,
December 1, 2009;
34(6):
1408 - 1416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Martinelli, G. Ryan, J. F. Seymour, L. Nassi, S. Steffanoni, A. Alietti, L. Calabrese, G. Pruneri, L. Santoro, M. Kuper-Hommel, et al.
Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group
Ann. Onc.,
December 1, 2009;
20(12):
1993 - 1999.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Paulli, L. Arcaini, M. Lucioni, E. Boveri, D. Capello, F. Passamonti, M. Merli, S. Rattotti, D. Rossi, R. Riboni, et al.
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT
Ann. Onc.,
October 25, 2009;
(2009)
mdp454v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Burger, P. Ghia, A. Rosenwald, and F. Caligaris-Cappio
The microenvironment in mature B-cell malignancies: a target for new treatment strategies
Blood,
October 15, 2009;
114(16):
3367 - 3375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Stasi, M. L. Evangelista, M. Brunetti, S. Bussa, R. Maritati, A. Gallo, L. Turrini, S. Taccogna, A. Crescenzi, and F. Angelini
Primary Gastric Plasmacytoma and Helicobacter pylori Infection
J. Clin. Oncol.,
January 1, 2009;
27(1):
150 - 153.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tuomisto, M. Sund, J. Tahkola, A. Latvanlehto, E.-R. Savolainen, H. Autio-Harmainen, A. Liakka, R. Sormunen, J. Vuoristo, A. West, et al.
A Mutant Collagen XIII Alters Intestinal Expression of Immune Response Genes and Predisposes Transgenic Mice to Develop B-Cell Lymphomas
Cancer Res.,
December 15, 2008;
68(24):
10324 - 10332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Morton, S. S. Wang, W. Cozen, M. S. Linet, N. Chatterjee, S. Davis, R. K. Severson, J. S. Colt, M. A. Vasef, N. Rothman, et al.
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes
Blood,
December 15, 2008;
112(13):
5150 - 5160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bigot-Corbel, M. Gassin, I. Corre, D. Le Carrer, O. Delaroche, and S. Hermouet
Hepatitis C virus (HCV) infection, monoclonal immunoglobulin specific for HCV core protein, and plasma-cell malignancy
Blood,
November 15, 2008;
112(10):
4357 - 4358.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Colombat, H. Mal, C. Copie-Bergman, J. Diebold, D. Damotte, P. Callard, M. Fournier, J.-P. Farcet, M. Stern, and M.-H. Delfau-Larue
Primary cystic lung light chain deposition disease: a clinicopathologic entity derived from unmutated B cells with a stereotyped IGHV4-34/IGKV1 receptor
Blood,
September 1, 2008;
112(5):
2004 - 2012.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Schollkopf, M. Melbye, L. Munksgaard, K. E. Smedby, K. Rostgaard, B. Glimelius, E. T. Chang, G. Roos, M. Hansen, H.-O. Adami, et al.
Borrelia infection and risk of non-Hodgkin lymphoma
Blood,
June 15, 2008;
111(12):
5524 - 5529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. M L Cohen, J. Sweetenham, and A. D Singh
Ocular adnexal lymphoma. What is the evidence for an infectious aetiology?
Br J Ophthalmol,
April 1, 2008;
92(4):
446 - 448.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Portlock, P. Hamlin, A. Noy, W. Chey, C. A. Gaydos, L. Palomba, I. Schwartz, S. Corcoran, L. Rosenzweig, D. Walker, et al.
Infectious disease associations in advanced stage, indolent lymphoma (follicular and nonfollicular): developing a lymphoma prevention strategy
Ann. Onc.,
February 1, 2008;
19(2):
254 - 258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. de Boer, R. F. Hiddink, M. Raderer, N. Antonini, B. M. P. Aleman, H. Boot, and D. de Jong
Dissemination patterns in non-gastric MALT lymphoma
Haematologica,
February 1, 2008;
93(2):
201 - 206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Kahl and D. Yang
Marginal Zone Lymphomas: Management of Nodal, Splenic, and MALT NHL
Hematology,
January 1, 2008;
2008(1):
359 - 364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Morton, O. Landgren, N. Chatterjee, D. Castenson, R. Parsons, R. N. Hoover, and E. A. Engels
Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients
Blood,
December 15, 2007;
110(13):
4599 - 4605.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Bianchettin, C. Bonaccini, R. Oliva, A. Tramontano, A. Cividini, M. Casato, G. Merlini, E. Silini, and M. U. Mondelli
Analysis of Hepatitis C Virus Hypervariable Region 1 Sequence from Cryoglobulinemic Patients and Associated Controls
J. Virol.,
May 1, 2007;
81(9):
4564 - 4571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Engels
Infectious Agents as Causes of Non-Hodgkin Lymphoma
Cancer Epidemiol. Biomarkers Prev.,
March 1, 2007;
16(3):
401 - 404.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P Arnaud, M-C Escande, M Lecuit, P Validire, C Levy, C Plancher, A Vincent-Salomon, N Brousse, P de Cremoux, O Hermine, et al.
Hepatitis C virus infection and MALT-type ocular adnexal lymphoma
Ann. Onc.,
February 1, 2007;
18(2):
400 - 401.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L Arcaini, S Burcheri, A Rossi, M Paulli, R Bruno, F Passamonti, E Brusamolino, A Molteni, A Pulsoni, M. Cox, et al.
Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT
Ann. Onc.,
February 1, 2007;
18(2):
346 - 350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Florins, N. Gillet, B. Asquith, C. Debacq, G. Jean, I. Schwartz-Cornil, M. Bonneau, A. Burny, M. Reichert, R. Kettmann, et al.
Spleen-Dependent Turnover of CD11b Peripheral Blood B Lymphocytes in Bovine Leukemia Virus-Infected Sheep
J. Virol.,
December 15, 2006;
80(24):
11998 - 12008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Halfdanarson, S. Markovic, U Kalokhe, and M Luppi
A non-chemotherapy treatment of a primary effusion lymphoma: durable remission after intracavitary cidofovir in HIV negative PEL refractory to chemotherapy
Ann. Onc.,
December 1, 2006;
17(12):
1849 - 1850.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. I. Bussiere, R. Chaturvedi, M. Asim, K. L. Hoek, Y. Cheng, J. Gainor, A. Scholz, W. N. Khan, and K. T. Wilson
Low Multiplicity of Infection of Helicobacter pylori Suppresses Apoptosis of B Lymphocytes.
Cancer Res.,
July 1, 2006;
66(13):
6834 - 6842.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|